BIOMAT Database Logo BIOMAT Database Logo

Relevance of the quantification of apolipoprotein E in the cerebrospinal fluid in Alzheimer's disease. 1996

D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
INSERM U422, Faculté de Médecine, Lille, France.

Apolipoprotein E (Apo E), one of the major structural and functional apolipoproteins, has recently been implicated in the pathogenesis of Alzheimer's disease (AD). Several studies revealed that Apo E4 isoform is associated with the pathogenic process in AD. A significant reduction of cerebrospinal fluid (CSF) Apo E level in AD patients has been reported in two studies. To further investigate the physiopathological significance of such a variation of Apo E concentration in the CSF, we performed a quantification of Apo E by an enzyme linked immunosorbent assay (ELISA). There were no significant differences in CSF Apo E level between AD cases and control subjects or patients suffering from other neurological diseases. Gender, age and Apo E phenotype explained none of CSF Apo E concentration variability.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
Clinical relevance of the quantification of apolipoprotein E in cerebrospinal fluid.
February 1991, Clinica chimica acta; international journal of clinical chemistry,
D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
Cerebrospinal fluid apolipoprotein E is reduced in Alzheimer's disease.
December 1994, Neuroreport,
D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients.
November 2022, Alzheimer's research & therapy,
D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
Cerebrospinal fluid apolipoprotein E concentration and progression of Alzheimer's disease.
January 2015, Journal of Alzheimer's disease : JAD,
D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
Cerebrospinal fluid apolipoprotein E level is increased in late-onset Alzheimer's disease.
January 1997, Journal of the neurological sciences,
D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.
May 2013, American journal of Alzheimer's disease and other dementias,
D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
Metrologically Traceable Quantification of 3 Apolipoprotein E Isoforms in Cerebrospinal Fluid.
July 2023, Clinical chemistry,
D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
The relevance of apolipoprotein E polymorphism to Alzheimer's disease.
January 1999, Indian journal of clinical biochemistry : IJCB,
D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease.
January 2016, Journal of the neurological sciences,
D Lefranc, and P Vermersch, and J Dallongeville, and C Daems-Monpeurt, and H Petit, and A Delacourte
Levels of cerebrospinal fluid apolipoprotein E in patients with Alzheimer's disease and healthy controls.
March 1997, Neuroscience letters,
Copied contents to your clipboard!